Novo Nordisk threatens legal action against Hims & Hers for "duping" public with cheap compounds of its popular weight-loss ...

Scientists have uncovered promising clues that compounds found in Aloe vera could play a role in fighting Alzheimer’s disease ...

Hims & Hers Health Inc. HIMS has decided to cease offering its compounded semaglutide pill. Hims & Hers Explains Its Decision Hims & Hers' decision to stop offering the $49 version of Novo Nordisk A/S ...

Sought-after ashwagandha supplements could soon be easier than ever to make. Scientists have engineered yeast to produce the ...

MEDVi has a physician-monitored telehealth platform that enables patients to receive GLP-1 weight loss therapy through linking with licensed clinicians, compounded drugs via licensed pharmacies and ...

Following escalating legal threats from federal regulators regarding plans to sell an unapproved form of Novo Nordisk’s Wegovy pill, Hims said it “decided to stop offering access” to the treatment.

Hims & Hers said it would stop selling its new compounded semaglutide pill after "constructive conversations with stakeholders across the industry." ...

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two ...

Hims & Hers Health Inc. announced it will stop selling a copycat version of Novo Nordisk's Wegovy weight-loss pill two days ...

The crisis is compounded by a critical shortage of affordable, properly stored antivenom.

After FDA probes and legal threats, Hims pulled the plug.

New credential formally recognizes pharmacy technicians as essential leaders in medication error prevention and patient ...